Tus kws kho mob
QP82-20 Commercial Pharmacy Benefit Exclusion for Amzeeq™ (minocycline) foam, brimonidine ophthalmic solution 0.15% and ProAir® (albuterol sulfate) HFA
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 26, 2020
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 2471 - 2480 ntawm 4139
Tus kws kho mob
P40-20 New Medical, Medical Drug and Behavioral Health Policy Management Updates – Effective August 3, 2020
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 01, 2020
Tus kws kho mob
2020 September Provider Press
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 19, 2020
Tus kws kho mob
PCA-Provider-Information-Form-102215.pdf
Tus kws kho mob
QP76-20 Outlier Outpatient Therapy Management Program
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 12, 2020
Tus kws kho mob
QP74-20 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Isturisa PA with QL
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 12, 2020
Tus kws kho mob
QP73-20 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Bempedoic Acid PA with QL
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 12, 2020
Tus kws kho mob
QP72-20 MHCP Pharmacy Benefit Update – Pharmacy Benefit Exclusion for Anjeso™, Fetroja®, Herzuma®, Ontruzant®, Potassium Phosphates, Scenesse® and Trazimera™
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 12, 2020
Tus kws kho mob
QP71-20 MHCP Pharmacy Benefit Update: Pharmacy Benefit Exclusion for Phesgo™, Uplizna™, and Zepzelca™
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 12, 2020